Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
about
Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemiaThe epigenetic landscape of acute myeloid leukemiaLow dose cytarabine monotherapy for acute myeloid leukaemiaHypomethylating agents for adult patients with acute myeloid leukaemiaThe effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemiaIdarubicin compared to other anthracyclines for treatment of newly diagnosed acute myeloid leukaemiaHypomethylating agents for adult patients with acute myeloid leukaemiaLow dose cytarabine monotherapy for acute myeloid leukaemiaUse of Flow Cytometry in Clinical PracticeUnderground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer CellsStem Cell Modeling of Core Binding Factor Acute Myeloid LeukemiaAcute Myeloid Leukemia: A Concise ReviewMonitoring minimal residual disease in acute myeloid leukaemia: a review of the current evolving strategiesRisk factors for relapse after allogeneic transplantation in acute myeloid leukemiaPrognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisDefining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive TherapiesAn update of current treatments for adult acute myeloid leukemiaMolecular Genetic Markers in Acute Myeloid LeukemiaTreatment of Acute Myeloid Leukemia in Adolescent and Young Adult PatientsVolasertib for AML: clinical use and patient considerationThe cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesDiscovery and development of the Polo-like kinase inhibitor volasertib in cancer therapyPost-remission therapy for acute myeloid leukemiaAllogeneic stem cell transplantation in first complete remissionMolecular prognostic factors in cytogenetically normal acute myeloid leukemiaYou eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaThe clinically relevant pharmacogenomic changes in acute myelogenous leukemiaProgress in acute myeloid leukemiaAnimal models of leukemia: any closer to the real thing?Granulocytic sarcoma: a systematic reviewFLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysisNext generation sequencing of acute myeloid leukemia: influencing prognosis.The prognostic and functional role of microRNAs in acute myeloid leukemiaTET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia.Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia
P2860
Q21132375-57C6D6D9-A6AC-498E-B08F-D31004120FF9Q21284742-5286106E-0F5B-447A-B470-BC65A6367820Q24186270-1FF03EFE-466A-4236-98CE-DF995F1763F6Q24186284-FCFDD3E5-D4A8-4BB2-8A27-F192C11F169BQ24187297-E92E53E5-87FE-49D3-BFDB-56BE166F95D3Q24200407-D400F288-5F45-4A4E-8F91-8C72367D4E99Q24234645-2FE36DCD-11DC-4954-88A7-3974908C11E8Q24234680-A747A4D8-5E75-4122-8063-5FFEC3DFD946Q26749006-273E4547-996F-4468-919D-011F70FFB9C6Q26751011-1F04DDB6-E2F9-4ECA-B3B1-0A70D5C5586EQ26765858-1C418A06-E3CA-4AB7-8F36-38D296261A05Q26766719-C4B8A877-9F04-4950-8631-8A913E54146FQ26770394-168927A4-1CD1-4678-A26A-AE80017DDE16Q26771438-12D6E9BB-5392-41A2-911B-E749E2A3EC66Q26771740-85358352-25C4-4DDC-8978-A2C5B4D96393Q26772235-3C4B614A-B269-46CA-ADAD-E5F9C0C13432Q26776396-E4539178-B6BE-471D-877C-B8CC14A8D68BQ26799606-1A145ED0-7A1B-4750-8BB1-0F729AC1A88CQ26799609-5686CC96-96B8-4262-B50E-C891EBEA67DDQ26801131-65B6C8E0-C093-4D91-9BF0-7E697F4AA2EEQ26853348-6E2DBA18-4750-4F2B-BCE7-43DF03A9D665Q26991736-ECD16A47-F170-4F71-B307-297D4EF0E6EEQ26995867-91FCD496-22FA-4D6C-846F-AD39723E4B82Q26996818-5D0914B5-8F4F-4812-A274-5DC09055CD23Q26998811-B671ED74-9524-46CC-A48B-5CB8E2DAB0EEQ26998971-AB157B8A-CE56-4D3F-BF95-8E8E5950BB90Q27014790-B012603D-3619-4508-AF00-21F07C785775Q27024006-F00631BA-6AF7-4EFC-9750-B9CD9FD5A0D4Q27026520-74CEED53-7D46-404A-B944-A4A8ACDAC814Q27027798-637F4C42-D3A5-4290-BA9B-785E42D6B78BQ27028163-2D9B5F37-F64D-4331-B3C5-D290942930ADQ27336142-47402EBA-E444-4816-B0BA-AE5D8482FE39Q27690776-FEF9F124-59B2-4149-ADB7-9FDD8E94A80AQ27693865-F658202C-08E5-446E-9342-4897CBA4F4EFQ27851621-1C638174-C659-468D-8B08-B5A3BC1B1803Q27851679-B134618B-7C3A-46A7-A114-844B0A48C3CDQ27851686-F29ED432-4BCC-4388-B607-56716A34BAD1Q27851689-87C7ED6D-6FA1-4EFD-8ACD-18CA7BE0EE38Q27851694-3298606A-13AB-49C7-8370-0B8F61C9F89CQ27851713-5E98F804-30C9-4F08-9512-DC7B28C072CB
P2860
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@ast
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@en
type
label
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@ast
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@en
prefLabel
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@ast
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@en
P2093
P50
P3181
P1433
P1476
Diagnosis and management of ac ...... lf of the European LeukemiaNet
@en
P2093
Alan K Burnett
Bob Löwenberg
Clara D Bloomfield
David Grimwade
Dietger Niederwieser
Elihu H Estey
European LeukemiaNet
Francesco Lo-Coco
Frederick R Appelbaum
Gert J Ossenkoppele
P304
P3181
P356
10.1182/BLOOD-2009-07-235358
P407
P577
2009-10-30T00:00:00Z